argenx SE
Below you will find information from the register publication of inside information. The information has been provided by the organisation.
Registration date
27 jul 2026 - 07:00
Statutory name
argenx SE
Title
argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class anti-CD122 Antibody, FB102, to its Immunology Pipeline
Date last update: 27 July 2026